Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Vical Inc. (VICL) Vical Inc. (VICL) said Merck & Co. Inc.
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury